Concepedia

Pabak Mukhopadhyay

PM

Statistics

Publications

18

Citations

5.5K

H-Index

17

Active since

1999

Affiliations

Sarah Cannon(Current)

University of Miami

The University of Texas MD Anderson Cancer Center

Cornell University

Novartis (United States)

Pabak Mukhopadhyay is an author at Sarah Cannon specializing in pharmacology, cancer pharmacology, and medicine.

Publications per year

1999–2013

18

Publications

18

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +9

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

, , +14

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients

Ira M. Jacobson, Robert S. Brown, Bradley Freilich et al. · Hepatology · 2007 · 306 citations · Full text

, , +17

Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy

Thierry Poynard, Massimo Colombo, Jordi Bruix et al. · Gastroenterology · 2009 · 235 citations · Full text

, , +15

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

Boris Kerzner, John Corbelli, Stephan C. Sharp et al. · The American Journal of Cardiology · 2003 · 217 citations

, , +12

1–5 of 18